Global Biological Specimen Preservation & Handling Market Strategic Research Report

Scope of the Report

The global Biological Specimen Preservation & Handling market size is predicted to grow from US$ 5,478 million in 2025 to US$ 9,851 million in 2032; it is expected to grow at a CAGR of 8.7% from 2026 to 2032.

Biological sample storage and processing services refer to third-party services that manage human, animal, or microbial samples, providing end-to-end or modular workflows including sample receipt, identification registration, barcode tracking, pre-processing, aliquoting, refrigerated/frozen/ultra-low temperature/liquid nitrogen storage, inventory management, inbound and outbound logistics, transport, and eventual disposal. Essentially, these services constitute “sample asset management plus cold chain compliant operations.” The overall gross margin is approximately 48%.

The core demand for biological sample storage and processing comes from drug development, clinical trials, diagnostic development, and advanced therapies. Pharmaceutical companies and CROs increasingly outsource biobanking, cold chain management, sample logistics, and tracking to professional institutions, as any loss, uncontrolled freeze-thaw, or incomplete chain-of-custody records can directly impact clinical data quality and regulatory compliance.

Industry growth is driven not simply by an increase in sample quantity but by higher sample value. With the rise of oncology, immunology, rare diseases, companion diagnostics, cell therapies, and gene therapies, requirements for PBMCs, cells, tissues, RNA, viral vectors, and therapeutic-grade retained samples in terms of temperature zones, timing, viability, and traceability have significantly increased. The competitive landscape is concentrating around “global network + compliance capability + data systems.” Lower-end frozen storage faces regional competition and price pressure, while liquid nitrogen storage, GxP/GMP compliance, cell therapy, multinational clinical trial sample management, and high-value sample transfers remain high-barrier segments.

Over the next six years, the market is expected to grow from USD 6.1 billion in 2026 to USD 9.1 billion by 2031, driven primarily by more complex clinical trials, the industrialization of advanced therapies, digital sample management, and pharmaceutical outsourcing for cost reduction. Overall, this is a moderately sized professional life sciences service market with high client stickiness, strong compliance barriers, and stable gross margins.

This report presents a comprehensive overview of the global Biological Specimen Preservation & Handling market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Storage Only
• Sample Processing
• Inventory Management
• Logistics Management
• Full Service
• Other Services

Segment by Storage Condition

• Controlled Ambient
• Refrigerated
• Frozen
• Ultra-Low
• Cryogenic
• Special Conditions

Segment by Specimen Form

• Fluid Specimens
• Analytical Tissue Specimens
• Cell Specimens
• Molecular Specimens
• Microbial Specimens
• Gross Anatomical Specimens
• Other Specimens

Segment by Application

• Drug R&D
• Diagnostics
• Medical Training
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Biological Specimen Preservation & Handling market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Drug R&D, Diagnostics, Medical Training evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact